Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Current Assets: 2014-2025

Historic Current Assets for AC Immune (ACIU) over the last 12 years, with Sep 2025 value amounting to $142.2 million.

  • AC Immune's Current Assets fell 34.33% to $142.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.2 million, marking a year-over-year decrease of 34.33%. This contributed to the annual value of $142.2 million for FY2025, which is N/A change from last year.
  • Per AC Immune's latest filing, its Current Assets stood at $142.2 million for FY2025, which was up 72,322.66% from $196,335 recorded in FY2024.
  • In the past 5 years, AC Immune's Current Assets registered a high of $221.8 million during FY2021, and its lowest value of $141,092 during FY2023.
  • Its 3-year average for Current Assets is $47.5 million, with a median of $196,335 in 2024.
  • In the last 5 years, AC Immune's Current Assets plummeted by 99.89% in 2023 and then soared by 39.15% in 2024.
  • Yearly analysis of 5 years shows AC Immune's Current Assets stood at $221.8 million in 2021, then slumped by 40.04% to $133.0 million in 2022, then tumbled by 99.89% to $141,092 in 2023, then soared by 39.15% to $196,335 in 2024, then reached $142.2 million in 2025.